Yash Rathod (@yashrathod_75) 's Twitter Profile
Yash Rathod

@yashrathod_75

Co-founder | Origin

ID: 1000783913952804864

linkhttp://www.origin.bio calendar_today27-05-2018 17:00:53

297 Tweet

233 Takipçi

432 Takip Edilen

Y Combinator (@ycombinator) 's Twitter Profile Photo

Origin (Origin) is using AI to make safer cell & gene therapies for diseases like cancer. Their model designs DNA switches & dials to program precise gene expression patterns in disease cells. Congrats on the launch Yash Rathod and malhar! ycombinator.com/launches/PMG-o…

Yash Rathod (@yashrathod_75) 's Twitter Profile Photo

We're still in the early days of durable and long lasting drugs based on transcriptional control - similar to where mRNA medicines were many years ago! With AI designed regulatory DNA and millions of sequences we're lab testing, we aim to precisely program gene expression

Naman Ambavi (@namanambavi) 's Twitter Profile Photo

I met Yash Rathod a few weeks ago and was struck by the depth of research the team has done. Beating AlphaGenome was only the first step, but they've gone meaningfully beyond it. Rooting for you guys. Origin

Hunter (@hunterharloff) 's Twitter Profile Photo

Transformers extending to bio is one of those things that just feels obvious - what is the molecular machinery of life, if not a language? Yash & Malhar are the real deal. Wicked sharp. Excited to support them as they shred legacy approaches.

Ankit Gupta (@guptaankitv) 's Twitter Profile Photo

This is a very special team. True pair of polymaths at the intersection of computer science and biology. Their first model beat Deepmind's AlphaGenome on benchmarks and they're now using that to design cell and gene therapies. Congrats on the launch!

malhar (@malhar317) 's Twitter Profile Photo

Cell and gene therapies have the potential to offer a much higher quality of life to patients. Getting transcriptional control right is going to unlock a whole new class of them. Happy to share a small preview into Axis’ ability to design novel regulatory DNA sequences. It’s so

Cell and gene therapies have the potential to offer a much higher quality of life to patients. Getting transcriptional control right is going to unlock a whole new class of them.

Happy to share a small preview into Axis’ ability to design novel regulatory DNA sequences. It’s so
Y Combinator (@ycombinator) 's Twitter Profile Photo

.Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. Ditto Bio is using AI to identify these natural, drug-like proteins and